RCT looking at HRQoL with two kinds of ascetic drains in untreatable cirrhosis patients. The study will compare an alternative intervention, insertion of a palliative tunnelled long-term abdominal drain (Group 1 intervention - LTAD), to standard of care large volume paracentesis (Group 2 intervention - LVP) in the management of refractory ascites.

The aim of the Q-ABC study is to address the current paucity of information available to patients and clinicians facing treatment decisions where increasingly evidence is showing surgery and radiotherapy can provide equivalent overall survival.

This online survey aimed to gather information from people living with multiple myeloma about their understanding of the condition and the words and phrases used to describe their diagnosis, treatment and support. The survey explored what doctors and nurses said or did that helped or hindered understanding, and what family or friends have said or done that was helpful or not so helpful.

The survey has now closed and the data are being analysed for publication.

In order to develop an educational programme to help communication professionals working with d/Deaf and deaf-blind people (e.g. sign language interpreters) better understand what they may be required to interpret in cancer consultations, we are conducting a survey to find out what communication professionals feel are the biggest challenges when working in cancer consultations.

There is interest worldwide about using a drug called a PARP inhibitor (PARPi) in people with BRCA 1 or BRCA 2 gene changes. These drugs already work in patients with cancer who have gene changes. We hope that PARP inhibitors given to those with gene changes who do not have cancer will stop a cancer developing. Before doctors can design a chemoprevention trial using this drug, we need to find out the preferences and acceptability of such a study. Initial insights gained from members of the public - in this instance women - will help with trial design and the sort of information required.